TEST, IMMUNITY, CELL MEDIATED, MYCOBACTERIUM TUBERCULOSIS
PMA番号：P180047 · 2026-09-24
広告
医療機器の概要
TEST, IMMUNITY, CELL MEDIATED, MYCOBACTERIUM TUBERCULOSIS is the device name listed in this FDA 510(k) record. The listed applicant is DiaSorin, Inc.. It received FDA 510(k) clearance on 2026-09-24. The device is classified under product code NCD. It was reviewed by the MI advisory panel.
よくある質問
What is the TEST, IMMUNITY, CELL MEDIATED, MYCOBACTERIUM TUBERCULOSIS?
TEST, IMMUNITY, CELL MEDIATED, MYCOBACTERIUM TUBERCULOSIS is a medical device that received FDA 510(k) clearance on 2026-09-24. The listed applicant is DiaSorin, Inc..
When did TEST, IMMUNITY, CELL MEDIATED, MYCOBACTERIUM TUBERCULOSIS receive FDA 510(k) clearance?
The clearance date for TEST, IMMUNITY, CELL MEDIATED, MYCOBACTERIUM TUBERCULOSIS can be found in the official FDA records.
Who is the listed applicant for TEST, IMMUNITY, CELL MEDIATED, MYCOBACTERIUM TUBERCULOSIS?
The FDA 510(k) record lists DiaSorin, Inc. as the applicant. This does not by itself establish the device manufacturer.
What is the FDA product code for TEST, IMMUNITY, CELL MEDIATED, MYCOBACTERIUM TUBERCULOSIS?
The FDA product code for TEST, IMMUNITY, CELL MEDIATED, MYCOBACTERIUM TUBERCULOSIS is NCD.
関連する臨床試験
関連レコードは、名称、製品コード、その他のメタデータを使用して自動的にマッチングされます。マッチは検証された臨床的、科学的、企業的、または規制上の関係を確立するものではありません。リンクされた公式情報源をご確認ください。
NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDEDNCT07095751膀胱癌を診断するための人工知能（AI）アシストドのUro-Camカテーテル評価システムNOT_YET_RECRUITING
公式ソース
FDAデータベースで見る →データはFDA Open APIから取得しています。最新かつ権威ある情報については、常に公式レコードを参照してください。
広告